Filana Therapeutics FLNA
NASDAQ FLNA
$0.66 -0.03 (-4.24%)
At close: Oct 21, 2026 · 4:00 PM EDT

Filana Therapeutics (FLNA) EV to CFO (2011)

Updated

Filana Therapeutics' EV to CFO came in at 611.14 for Q2 2011.

Analysis

Filana Therapeutics (FLNA) EV to CFO (2011) Analysis & Trends

Over the trailing twelve months to Jun 30, 2011, Filana Therapeutics reported EV to CFO of 471.92.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Filana Therapeutics 32.11 Mn -338.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2011 611.14
API Access

Filana Therapeutics EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=FLNA&period=max&api_key=YOUR_API_KEY